Veterinary Artificial Reproduction Market by Product (Equipment, Reagents & Kits, and Others), Technique (Artificial Insemination, In-Vitro Fertilization (IVF) Technology and Others), and End User (Veterinary Hospitals, Veterinary Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
- ALL4676952
- 169 Pages
- September 2021
- Diagnostic and Biotech
Artificial reproduction is the technique in which semen with living sperms is collected from male and introduced into female reproductive tract at proper time with the help of instruments. This has been found to result in a normal offspring.
The technique has been commercially available for over 60 years and has been utilized very effectively in the cattle and dairy industry. Artificial reproduction can reduce many of the risks involved with animal breeding and disease transmission, which acts as a key factor in the market growth. Increase in productivity using artificial reproduction technology propels the market growth. In addition, female offspring born through artificial reproduction are found to produce more milk than normal offspring. The use of semen extenders containing antibiotics is also helpful in preventing transmission of bacterial diseases.
Furthermore, the entire procedure of reproduction is considered to be much more hygienic than natural mating. Moreover, as production conditions and needs of farmers evolve, many of animal breeds are no longer suitable for majority of farms. However, artificial insemination is used as a preferred reproduction method for such breeds and makes it possible to continue to farm the breeds in-situ.
Rise in human population is also a major factor leading to continuous need for growing animal productivity. Moreover, associated advantages such as increased efficiency of bull usage, genetic selection, decreased cost of housing, handling bull, and safety for farmers and animals are anticipated to increase adoption of artificial insemination during the forecast period. Furthermore, increase in calf prices are also leading to adoption of artificial insemination technology among farmers. According to a report published by the Beef Cattle Research Council in March 2018, bull prices were $ 5,500 to $ 8,000 in Canada from 2015 to 2016. These prices decreased from $ 4,500 to $ 6,500 from 2017 to 2018, owing to the adoption of artificial insemination.
The demand for the genetically superior breed of animals is increasing, which, in turn, is increasing demand for artificial reproduction procedures in animals. Furthermore, the industry players are continuously trying to develop new products, along with partnerships, collaboration, and acquisitions to sustain their market share. For instance, in August 2020, Cogent collaborated with AB Europe, a sheep breeding company, to launch a novel sexed semen service for sheep producers in the U.K. In May 2018, Recombinetics partnered with SEMEX for the implementation of a precision breeding program that improved animal health and well-being through hornless dairy cattle genetics. Moreover, increased adoption of cattle for artificial insemination procedures, rising milk consumption, and production of beef are the key factors responsible for the significant growth of the veterinary artificial reproduction market.
The veterinary artificial reproduction market is segmented on the basis of product, technique, end user, and region. By product, the market is categorized into equipment, reagents & kits, and others. By technique, the market is divided into artificial insemination, in-vitro fertilization (IVF) technology, and others. By end user, it is fragmented into veterinary hospitals, veterinary clinics, and others.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Some of the major companies that operate in the global veterinary artificial reproduction market are Bovine Elite LLC, KRUUSE, Agtech Inc., IMV Technologies, Zoetis Inc., Neogen Corporation, National Meditek, Swine Genetics International, Select Sires Inc., SEMEX.
KEY BENEFITS FOR STAKEHOLDERS
• This report provides an extensive analysis of the current and emerging market trends and dynamics in the global veterinary artificial reproduction market to identify the prevailing opportunities.
• This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.
• Region- & country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Product
o Equipment
o Reagents and Kits
o Others
By Technique
o Artificial Insemination
o In- Vitro Fertilization (IVF) Technology
o Others
By End User
o Veterinary Hospitals
o Veterinary Clinics
o Others
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
o LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
KEY MARKET PLAYERS
• Bovine Elite LLC
• KRUUSE
• Agtech Inc.
• IMV Technologies
• Zoetis Inc.
• Neogen Corporation
• National Meditek
• Swine Genetics International
• Select Sires Inc.
• SEMEX
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.3.1.Top player positioning
3.4.Market dynamics
3.4.1.Drivers, restraints, and opportunity
3.4.2.Drivers
3.4.2.1.Increase in adoption veterinary artificial insemination (AI)
3.4.3.Restraint
3.4.3.1.Semen contamination restraint the market growth
3.4.4.Opportunities
3.4.4.1.Government support affecting animal health services influencing market growth
3.5.Impact of COVID-19 on the veterinary artificial reproduction market
CHAPTER 4:VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Equipment
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Reagents and Kits
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Others
4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE
5.1.Overview
5.1.1.Market size and forecast
5.2.Artificial Insemination
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.2.2.1.Market size and forecast, by end user
5.3.In- Vitro Fertilization (IVF) Technology
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.3.2.1.Market size and forecast, by end user
5.4.Others
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.4.2.1.Market size and forecast, by end user
CHAPTER 6:VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Veterinary Hospitals
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Veterinary Clinics
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Others
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key opportunities and forecast
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, by product
7.2.4.Market size and forecast, by technique
7.2.5.Market size and forecast, by end user
7.2.5.1.U.S.
7.2.5.1.1.U.S. market size and forecast, by product
7.2.5.1.2.U.S. market size and forecast, by technique
7.2.5.1.3.U.S. market size and forecast, by end user
7.2.5.2.Canada
7.2.5.2.1.Canada market size and forecast, by product
7.2.5.2.2.Canada market size and forecast, by technique
7.2.5.2.3.Canada market size and forecast, by end user
7.2.5.3.Mexico
7.2.5.3.1.Mexico market size and forecast, by product
7.2.5.3.2.Mexico market size and forecast, by technique
7.2.5.3.3.Mexico market size and forecast, by end user
7.3.Europe
7.3.1.Key opportunities and forecast
7.3.2.Market size and forecast, by country
7.3.3.Market size and forecast, by product
7.3.4.Market size and forecast, by technique
7.3.5.Market size and forecast, by end user
7.3.5.1.Germany
7.3.5.1.1.Germany market size and forecast, by product
7.3.5.1.2.Germany market size and forecast, by technique
7.3.5.1.3.Germany market size and forecast, by end user
7.3.5.2.France
7.3.5.2.1.France market size and forecast, by product
7.3.5.2.2.France market size and forecast, by technique
7.3.5.2.3.France market size and forecast, by end user
7.3.5.3.UK
7.3.5.3.1.UK market size and forecast, by product
7.3.5.3.2.UK market size and forecast, by technique
7.3.5.3.3.UK market size and forecast, by end user
7.3.5.4.Italy
7.3.5.4.1.Italy market size and forecast, by product
7.3.5.4.2.Italy market size and forecast, by technique
7.3.5.4.3.Italy market size and forecast, by end user
7.3.5.5.Spain
7.3.5.5.1.Spain market size and forecast, by product
7.3.5.5.2.Spain market size and forecast, by technique
7.3.5.5.3.Spain market size and forecast, by technique
7.3.5.6.Rest of Europe
7.3.5.6.1.Rest of Europe market size and forecast, by product
7.3.5.6.2.Rest of Europe market size and forecast, by technique
7.3.5.6.3.Rest of Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key opportunities and forecast
7.4.2.Market size and forecast, by country
7.4.3.Market size and forecast, by product
7.4.4.Market size and forecast, by technique
7.4.5.Market size and forecast, by end user
7.4.5.1.Japan
7.4.5.1.1.Japan market size and forecast, by product
7.4.5.1.2.Japan market size and forecast, by technique
7.4.5.1.3.Japan market size and forecast, by end user
7.4.5.2.China
7.4.5.2.1.China market size and forecast, by product
7.4.5.2.2.China market size and forecast, by technique
7.4.5.2.3.China market size and forecast, by end user
7.4.5.3.Australia
7.4.5.3.1.Australia market size and forecast, by product
7.4.5.3.2.Australia market size and forecast, by technique
7.4.5.3.3.Australia market size and forecast, by end user
7.4.5.4.India
7.4.5.4.1.India market size and forecast, by product
7.4.5.4.2.India market size and forecast, by technique
7.4.5.4.3.India market size and forecast, by technique
7.4.5.5.South Korea
7.4.5.5.1.South Korea market size and forecast, by product
7.4.5.5.2.South Korea market size and forecast, by technique
7.4.5.5.3.South Korea market size and forecast, by technique
7.4.5.6.Rest of Asia-Pacific
7.4.5.6.1.Rest of Asia-Pacific market size and forecast, by product
7.4.5.6.2.Rest of Asia-Pacific market size and forecast, by technique
7.4.5.6.3.Rest of Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key opportunities and forecast
7.5.2.Market size and forecast, by country
7.5.3.Market size and forecast, by product
7.5.4.Market size and forecast, by technique
7.5.5.Market size and forecast, by end user
7.5.5.1.Brazil
7.5.5.1.1.Brazil market size and forecast, by product
7.5.5.1.2.Brazil market size and forecast, by technique
7.5.5.1.3.Brazil market size and forecast, by end user
7.5.5.2.Saudi Arabia
7.5.5.2.1.Saudi Arabia market size and forecast, by product
7.5.5.2.2.Saudi Arabia market size and forecast, by technique
7.5.5.2.3.Saudi Arabia market size and forecast, by end user
7.5.5.3.South Africa
7.5.5.3.1.South Africa market size and forecast, by product
7.5.5.3.2.South Africa market size and forecast, by technique
7.5.5.3.3.South Africa market size and forecast, by end user
7.5.5.4.Rest of LAMEA
7.5.5.4.1.Rest of LAMEA market size and forecast, by product
7.5.5.4.2.Rest of LAMEA market size and forecast, by technique
7.5.5.4.3.Rest of LAMEA market size and forecast, by technique
TABLE 01.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 02.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR EQUIPMENT, BY REGION, 2020–2030($MILLION)
TABLE 03.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR REAGENTS AND KITS, BY REGION, 2020–2030($MILLION)
TABLE 04.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR OTHER, BY REGION, 2020–2030 ($MILLION)
TABLE 05.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 06.ARTIFICIAL INSEMINATION FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY REGION, 2020–2030($MILLION)
TABLE 07.ARTIFICIAL INSEMINATION FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY END USER, 2020–2030($MILLION)
TABLE 08.IN- VITRO FERTILIZATION (IVF) TECHNOLOGY FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 09.IN- VITRO FERTILIZATION (IVF) TECHNOLOGY FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 10.OTHERS FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 11.OTHERS FOR VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)
TABLE 12.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE, BY END USER, 2020–2030($MILLION)
TABLE 13.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR VETERINARY HOSPITALS, BY REGION, 2020–2028($MILLION)
TABLE 14.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR VETERINARY CLINICS, BY REGION, 2020–2030($MILLION)
TABLE 15.VETERINARY ARTIFICIAL REPRODUCTION MARKET REVENUE FOR OTHERS, BY REGION, 2020–2028($MILLION)
TABLE 16.VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY REGION, 2020–2030($MILLION)
TABLE 17.NORTH AMERICA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 18.NORTH AMERICA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 19.NORTH AMERICA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 20.NORTH AMERICA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 21.U.S. VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 22.U.S. VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 23.U.S. VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 24.CANADA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 25.CANADA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 26.CANADA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 27.MEXICO VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 28.MEXICO VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 29.MEXICO VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 30.EUROPE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 31.EUROPE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 32.EUROPE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 33.EUROPE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 34.GERMANY VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 35.GERMANY VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 36.GERMANY VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 37.FRANCE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 38.FRANCE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 39.FRANCE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 40.UK VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 41.UK VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 42.UK VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 43.ITALY VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 44.ITALY VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 45.ITALY VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 46.SPAIN VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 47.SPAIN VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 48.SPAIN VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 49.REST OF EUROPE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 50.REST OF EUROPE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 51.REST OF EUROPE VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 52.ASIA-PACIFIC VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 53.ASIA-PACIFIC VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 54.ASIA-PACIFIC VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 55.ASIA-PACIFIC VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 56.JAPAN VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 57.JAPAN VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 58.JAPAN VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 59.CHINA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 60.CHINA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 61.CHINA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 62.AUSTRALIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 63.AUSTRALIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 64.AUSTRALIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 65.INDIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 66.INDIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 67.INDIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 68.SOUTH KOREA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 69.SOUTH KOREA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 70.SOUTH KOREA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 71.REST OF ASIA-PACIFIC VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 72.REST OF ASIA-PACIFC VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 73.REST OF ASIA-PACIFC VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 74.LAMEA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 75.LAMEA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 76.LAMEA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 77.LAMEA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 78.BRAZIL VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 79.BRAZIL VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 80.BRAZIL VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 81.SAUDI ARABIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 82.SAUDI ARABIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 83.SAUDI ARABIA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 84.SOUTH AFRICA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 85.SOUTH AFRICA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 86.SOUTH AFRICA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER, 2020–2030($MILLION)
TABLE 87.REST OF LAMEA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 88.REST OF LAMEA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 89.REST OF LAMEA VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE, 2020–2030($MILLION)
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
